ABOUT US
There are more than 9 million immunocompromised people in the United States. Almost half a million of those represent a population that are moderately to severely immunocompromised and at highest risk for severe COVID-19, including stem cell and solid organ transplant patients as well as those with hematologic cancers.
At Invivyd, Inc., we take those numbers very seriously and we come to work each day on a mission to deliver protection from serious viral infectious diseases, beginning with SARS-CoV-2. Invivyd deploys a proprietary integrated technology platform unique in the industry designed to assess, monitor, develop, and adapt to create best in class antibodies.
In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates.
In October 2025, the FDA cleared the company's Investigational New Drug (IND) application and provided feedback to advance the company's REVOLUTION clinical program, Invivyd's development program for VYD2311, a vaccine alternative monoclonal antibody being investigated for the prevention of COVID-19.
Be part of making a difference. Be part of Invivyd.
Location: Northeast Preferred
Position Summary:
The Director of Biostatistics is a proven thought leader in statistical science with strong technical skills and a recent NDA/BLA track record provides direction on clinical development plans, protocols and analysis, reviews clinical study reports and regulatory submission materials, and ensures that standard procedures are followed within projects. This person is responsible for implementing consistent statistical conduct for the department and liaising with clinical research personnel to identify and meet their needs for statistical support. This person also interacts with the head of statistical programming and data management to synchronize prioritization of projects and, in some cases, represent biostatistics in meetings with executive committees, commercial, regulatory agencies, and external development partners in the absence of the Head of Biometrics.
Responsibilities:
- Applies statistical expertise to ensure innovative clinical trial designs, analysis methods and data displays; accountable to deliver high quality writing and supervision of statistical analysis plans
- Uses advanced statistical techniques to analyze clinical study data
- Performs clinical trial simulations to optimize clinical trial designs
- Ensures scientific integrity of the statistical methodology applied to clinical trials
- Provides input to development programs including filing strategies worldwide, study design, analytic methods, and endpoints that meet both regulatory and scientific requirements
- Collaborates with other functional areas within the company (clinical data management, clinical research, global drug safety, regulatory and project management)
- Makes presentations and may represent biostatistics to therapeutic leads, senior management, external collaborators, FDA meetings and medical and statistical meetings
- Provides statistical direction and technical oversight for projects requiring statistical input
- Supports the presentation and publication of clinical trial results and contribution to advances on statistical topics and presents at scientific conferences
- Clarifies project deliverables and timelines for statistical analysis and reporting and ensure that they are met
- Utilizes knowledge of methods for handling missing data, multiple comparisons and multiple endpoints, interim analyses, simulation techniques, adaptive designs, and bioinformatics
Requirements:
- PhD in statistics, biostatistics or equivalent area with 10+ years biopharmaceutical industry experience required. MS degree in related discipline with extensive industry and leadership experience (14+ years) can be considered
- Scientific programming experience with SAS or R
- Strong understanding of clinical trial processes and statistical programming requirements for regulatory submissions (regulatory submission experience including NDAs/MAAs is required)
- Experience in providing statistical support for medical affairs and market access activities is highly preferred
- Demonstrated ability to provide insight into patterns within data which sheds new light on optimal ways in which treatments should be used
- Ability to travel to New Haven 1x a month
Pay Range
Director: $184,000 - $245,000
Senior Director: $220,000 - $293,000
The pay range represents the expected full-time base salary for this role at the time of posting. Actual base pay will be determined based on a variety of factors, including relevant experience, skills, and education. In addition to base pay, this role is eligible for both an annual short-term incentive (e.g., bonus or sales incentive) and an annual long-term incentive (e.g., equity), reflecting our commitment to rewarding strong performance and long-term impact. Learn more about our total rewards by visiting https://www.invivyd.com/careers/.
At Invivyd we strive to create a welcoming and inclusive environment. Here all applicants will receive equal consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other applicable legally protected characteristics.
Invivyd is proud to be an equal opportunity employer.
We do not accept unsolicited resumes from agencies.
Top Skills
Similar Jobs
.png)
What you need to know about the Colorado Tech Scene
Key Facts About Colorado Tech
- Number of Tech Workers: 260,000; 8.5% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Lockheed Martin, Century Link, Comcast, BAE Systems, Level 3
- Key Industries: Software, artificial intelligence, aerospace, e-commerce, fintech, healthtech
- Funding Landscape: $4.9 billion in VC funding in 2024 (Pitchbook)
- Notable Investors: Access Venture Partners, Ridgeline Ventures, Techstars, Blackhorn Ventures
- Research Centers and Universities: Colorado School of Mines, University of Colorado Boulder, University of Denver, Colorado State University, Mesa Laboratory, Space Science Institute, National Center for Atmospheric Research, National Renewable Energy Laboratory, Gottlieb Institute
